Skip to main content

Table 3 Characteristics and outcomes of patients with spontaneous bacterial peritonitis due to extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella species (ESBL-EK), according to the effectiveness of the initial therapy

From: Clinical outcomes of spontaneous bacterial peritonitis due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiellaspecies: A retrospective matched case-control study

Characteristics Initial therapy P-value
  Effective (n = 8) Ineffective (n = 18)  
   Age (mean in year, SD) 62.1 ± 9.3 58.3 ± 10.4 0.363
   Male (n, %) 4 (50%) 15 (83%) 0.149
   Escherichia coli (n, %) 5 (63%) 12 (67%) 1.000
   Child-Pugh score (mean, SD) 10.4 ± 1.6 11.1 ± 1.6 0.330
   APACHE II score (mean, SD) 15.6 ± 3.8 15.6 ± 3.7 0.993
Outcomes    
   Initial response†    
Complete response (n, %) 1 (13%) 1 (6%) 0.529
Treatment failure (n, %) 2 (25%) 13 (72%) 0.038
   7-day mortality (n, %) 1 (13%) 8 (44%) 0.190
   30-day mortality (n, %) 1 (13%) 11 (61%) 0.036
  1. SD – standard deviation
  2. APACHE II – Acute Physiologic and Chronic Health Evaluation II
  3. † Initial response was assessed 72 hours after the initiation of empirical treatment
Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us